| pubmed-article:9041281 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9041281 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:9041281 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:9041281 | lifeskim:mentions | umls-concept:C0040162 | lld:lifeskim |
| pubmed-article:9041281 | lifeskim:mentions | umls-concept:C0879626 | lld:lifeskim |
| pubmed-article:9041281 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
| pubmed-article:9041281 | lifeskim:mentions | umls-concept:C0282116 | lld:lifeskim |
| pubmed-article:9041281 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:9041281 | lifeskim:mentions | umls-concept:C0238711 | lld:lifeskim |
| pubmed-article:9041281 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9041281 | pubmed:dateCreated | 1997-3-11 | lld:pubmed |
| pubmed-article:9041281 | pubmed:abstractText | The Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone (ACTOBAT) assessed the efficacy of 200 microg of thyrotropin-releasing hormone (TRH) in combination with glucocorticoids in the prevention of neonatal lung disease. This paper reports the 12-month follow-up of the infants from the trial completed in 1994. | lld:pubmed |
| pubmed-article:9041281 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9041281 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9041281 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9041281 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9041281 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9041281 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9041281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9041281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9041281 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9041281 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:9041281 | pubmed:issn | 1098-4275 | lld:pubmed |
| pubmed-article:9041281 | pubmed:author | pubmed-author:RobinsonJ SJS | lld:pubmed |
| pubmed-article:9041281 | pubmed:author | pubmed-author:CrowtherC ACA | lld:pubmed |
| pubmed-article:9041281 | pubmed:author | pubmed-author:HillerJ EJE | lld:pubmed |
| pubmed-article:9041281 | pubmed:author | pubmed-author:HaslamR RRR | lld:pubmed |
| pubmed-article:9041281 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:9041281 | pubmed:volume | 99 | lld:pubmed |
| pubmed-article:9041281 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9041281 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9041281 | pubmed:pagination | 311-7 | lld:pubmed |
| pubmed-article:9041281 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:meshHeading | pubmed-meshheading:9041281-... | lld:pubmed |
| pubmed-article:9041281 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9041281 | pubmed:articleTitle | Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone: adverse effects at 12-month follow-up. ACTOBAT Study Group. | lld:pubmed |
| pubmed-article:9041281 | pubmed:affiliation | Department of Obstetrics and Gynaecology, University of Adelaide, South Australia. | lld:pubmed |
| pubmed-article:9041281 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9041281 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:9041281 | pubmed:publicationType | Comment | lld:pubmed |
| pubmed-article:9041281 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:9041281 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9041281 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9041281 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9041281 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9041281 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9041281 | lld:pubmed |
